Reaction

Apraxia reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 1,465 reports · 45 co-occurring drugs

As of the last recalculation, Apraxia appears in 1,465 FAERS reports alongside 45 co-occurring drug terms. The strongest observed disproportionality signal is BLINATUMOMAB (PRR 26.2).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Blinatumomab	19	26.2	26.2
Paliperidone	38	23.7	23.8
Lithium Carbonate	25	21.3	21.3
Captopril	13	19.4	19.4
Haloperidol	31	18.5	18.5
Valproate Sodium	26	18.2	18.2
Haloperidol Lactate	31	18.2	18.2
Linagliptin	22	17.4	17.4
Quetiapine Fumarate	34	16.7	16.8
Telmisartan	20	16.1	16.1
Rivastigmine	21	16.1	16.1
Ganciclovir Sodium	11	14.9	14.9
Ganciclovir	10	14.0	14.0
Aripiprazole Oral	38	13.4	13.4
Aripiprazole Orally Disintegrating	38	13.4	13.4
Trimethoprim	11	13.4	13.4
Paroxetine Hydrochloride Hemihydrate	28	12.2	12.2
Paroxetine	28	11.9	11.9
Cenegermin-Bkbj	10	11.8	11.8
Olanzapine	81	11.3	11.3
Brivaracetam	7	11.1	11.1
Nevirapine	7	11.1	11.1
Dorzolamide Hydrochloride And Timolol Maleate	6	10.8	10.8
Indapamide	13	10.4	10.4
Daspone	7	10.3	10.3
Dapsone Gel, 5%	7	10.3	10.3
Efavirenz	8	10.2	10.3
Axicabtagene Ciloleucel	7	10.1	10.1
Primidone	7	9.8	9.8
Dapsone	7	9.4	9.4
Voriconazole Injection	14	9.2	9.2
Valproic Acid	19	8.7	8.7
Zidovudine	8	8.5	8.5
Voriconazole	18	8.5	8.5
Phenytoin	12	8.2	8.2
Clobazam	13	7.6	7.6
Clozapine	63	7.4	7.4
Levodopa	6	7.1	7.1
Travoprost	4	6.6	6.6
Pyrazinamide	4	6.1	6.1
Ravulizumab	5	5.3	5.3
Selinexor	3	4.9	4.9
Avapritinib	3	3.5	3.5
Brexpiprazole	4	3.4	3.4
Pimavanserin Tartrate	6	1.5	1.5

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.